Observational analysis reveals the FT3/FT4 ratio predicts relapse, suggesting its clinical use for monitoring pediatric Graves’ disease.
• The baseline FT3/FT4 ratio has limited value in predicting remission but may serve as a strong predictor of relapse, with a ratio 0.54 pmol/pmol showing high specifi city for relapse in pediatric Graves' disease.
No takes yet. Share an insight, caveat, or question.
Kara et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: